rs201039547

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1

The NM_138773.4(SLC25A46):​c.630C>T​(p.Tyr210Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,572,414 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

SLC25A46
NM_138773.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.299

Publications

1 publications found
Variant links:
Genes affected
SLC25A46 (HGNC:25198): (solute carrier family 25 member 46) This gene encodes a mitochondrial solute carrier protein family member. It functions in promoting mitochondrial fission, and prevents the formation of hyperfilamentous mitochondria. Mutation of this gene results in neuropathy and optic atrophy. [provided by RefSeq, Aug 2016]
SLC25A46 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary motor and sensory, type 6B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • pontocerebellar hypoplasia, type 1E
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary motor and sensory neuropathy type 6
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontocerebellar hypoplasia type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 5-110756711-C-T is Benign according to our data. Variant chr5-110756711-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.299 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000204 (31/152000) while in subpopulation EAS AF = 0.00232 (12/5182). AF 95% confidence interval is 0.00134. There are 1 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A46NM_138773.4 linkc.630C>T p.Tyr210Tyr synonymous_variant Exon 7 of 8 ENST00000355943.8 NP_620128.1 Q96AG3-1
SLC25A46NM_001303249.3 linkc.630C>T p.Tyr210Tyr synonymous_variant Exon 7 of 8 NP_001290178.1 Q96AG3-3
SLC25A46NM_001303250.3 linkc.357C>T p.Tyr119Tyr synonymous_variant Exon 7 of 8 NP_001290179.1 Q96AG3B4DY98
SLC25A46NR_138151.2 linkn.869C>T non_coding_transcript_exon_variant Exon 8 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A46ENST00000355943.8 linkc.630C>T p.Tyr210Tyr synonymous_variant Exon 7 of 8 1 NM_138773.4 ENSP00000348211.3 Q96AG3-1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
151882
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000236
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000272
AC:
60
AN:
220280
AF XY:
0.000308
show subpopulations
Gnomad AFR exome
AF:
0.0000672
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00299
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000766
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000136
AC:
193
AN:
1420414
Hom.:
1
Cov.:
29
AF XY:
0.000130
AC XY:
92
AN XY:
705854
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30836
American (AMR)
AF:
0.0000285
AC:
1
AN:
35038
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24900
East Asian (EAS)
AF:
0.00260
AC:
100
AN:
38484
South Asian (SAS)
AF:
0.000285
AC:
22
AN:
77110
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52784
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5594
European-Non Finnish (NFE)
AF:
0.0000556
AC:
61
AN:
1097146
Other (OTH)
AF:
0.000154
AC:
9
AN:
58522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152000
Hom.:
1
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41498
American (AMR)
AF:
0.00
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10526
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000236
AC:
16
AN:
67926
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000447
Hom.:
1
Bravo
AF:
0.000170
Asia WGS
AF:
0.000290
AC:
1
AN:
3460

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuropathy, hereditary motor and sensory, type 6B Benign:1
Aug 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.60
DANN
Benign
0.48
PhyloP100
-0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201039547; hg19: chr5-110092411; API